Literature DB >> 15207256

The blood-brain barrier: an overview: structure, regulation, and clinical implications.

Praveen Ballabh1, Alex Braun, Maiken Nedergaard.   

Abstract

The blood-brain barrier (BBB) is a diffusion barrier, which impedes influx of most compounds from blood to brain. Three cellular elements of the brain microvasculature compose the BBB-endothelial cells, astrocyte end-feet, and pericytes (PCs). Tight junctions (TJs), present between the cerebral endothelial cells, form a diffusion barrier, which selectively excludes most blood-borne substances from entering the brain. Astrocytic end-feet tightly ensheath the vessel wall and appear to be critical for the induction and maintenance of the TJ barrier, but astrocytes are not believed to have a barrier function in the mammalian brain. Dysfunction of the BBB, for example, impairment of the TJ seal, complicates a number of neurologic diseases including stroke and neuroinflammatory disorders. We review here the recent developments in our understanding of the BBB and the role of the BBB dysfunction in CNS disease. We have focused on intraventricular hemorrhage (IVH) in premature infants, which may involve dysfunction of the TJ seal as well as immaturity of the BBB in the germinal matrix (GM). A paucity of TJs or PCs, coupled with incomplete coverage of blood vessels by astrocyte end-feet, may account for the fragility of blood vessels in the GM of premature infants. Finally, this review describes the pathogenesis of increased BBB permeability in hypoxia-ischemia and inflammatory mechanisms involving the BBB in septic encephalopathy, HIV-induced dementia, multiple sclerosis, and Alzheimer disease.

Entities:  

Mesh:

Year:  2004        PMID: 15207256     DOI: 10.1016/j.nbd.2003.12.016

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  650 in total

1.  Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis.

Authors:  Celia M Ebrahimi; Tamsin R Sheen; Christian W Renken; Roberta A Gottlieb; Kelly S Doran
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Immortalized CNS pericytes are quiescent smooth muscle actin-negative and pluripotent.

Authors:  Paula Dore-Duffy; Afroza Mehedi; Xueqian Wang; Michael Bradley; Richard Trotter; Alexander Gow
Journal:  Microvasc Res       Date:  2011-04-15       Impact factor: 3.514

3.  Prestroke proteomic changes in cerebral microvessels in stroke-prone, transgenic[hCETP]-Hyperlipidemic, Dahl salt-sensitive hypertensive rats.

Authors:  Agnes Bergerat; Julius Decano; Chang-Jiun Wu; Hyungwon Choi; Alexey I Nesvizhskii; Ann Marie Moran; Nelson Ruiz-Opazo; Martin Steffen; Victoria Lm Herrera
Journal:  Mol Med       Date:  2011-04-14       Impact factor: 6.354

Review 4.  Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Authors:  Tyler A Kokjohn; Chera L Maarouf; Alex E Roher
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

5.  Cliniconeuropathologic correlations show astroglial albumin storage as a common factor in epileptogenic vascular lesions.

Authors:  Anna Raabe; Ann Kristin Schmitz; Katharina Pernhorst; Alexander Grote; Christian von der Brelie; Horst Urbach; Alon Friedman; Albert J Becker; Christian E Elger; Pitt Niehusmann
Journal:  Epilepsia       Date:  2012-03       Impact factor: 5.864

Review 6.  Neurovascular unit: a focus on pericytes.

Authors:  Inês Sá-Pereira; Dora Brites; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2012-02-28       Impact factor: 5.590

Review 7.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

8.  Hybrid magneto-plasmonic liposomes for multimodal image-guided and brain-targeted HIV treatment.

Authors:  Asahi Tomitaka; Hamed Arami; Zaohua Huang; Andrea Raymond; Elizette Rodriguez; Yong Cai; Marcelo Febo; Yasushi Takemura; Madhavan Nair
Journal:  Nanoscale       Date:  2017-12-21       Impact factor: 7.790

9.  Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin.

Authors:  Rokon Uz Zaman; Nihal S Mulla; Keegan Braz Gomes; Cherilyn D'Souza; Kevin Sean Murnane; Martin J D'Souza
Journal:  Int J Pharm       Date:  2018-07-19       Impact factor: 5.875

Review 10.  Pathogenesis and prevention of intraventricular hemorrhage.

Authors:  Praveen Ballabh
Journal:  Clin Perinatol       Date:  2013-12-12       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.